This inventor holds 1 USPTO granted patent. Top assignee: Paean Biotechnology Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Yun Sang Lee in Myositis Treatment
Introduction
Yun Sang Lee is a notable inventor based in Yongin-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of myositis. His innovative approach involves the use of isolated mitochondria as an active ingredient in his pharmaceutical compositions.
Latest Patents
Yun Sang Lee holds a patent for a pharmaceutical composition aimed at preventing or treating myositis. The patent is titled "Pharmaceutical Composition for Preventing or Treating Myositis, Comprising Isolated Mitochondria as Active Ingredient." This invention highlights his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Yun Sang Lee is currently associated with Paean Biotechnology Inc., where he continues to work on groundbreaking research and development in the pharmaceutical sector. His expertise and innovative mindset have positioned him as a valuable asset to the company and the industry at large.
Collaborations
He collaborates with talented individuals such as Kyuboem Han and Chun-Hyung Kim, contributing to a dynamic research environment that fosters innovation and creativity.
Conclusion
Yun Sang Lee's work in developing pharmaceutical compositions for myositis treatment showcases his dedication to improving healthcare solutions. His contributions are paving the way for advancements in medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile